Private_Equity.jpg

Businesses

Sous-titre

With 20 years of experience managing dedicated funds, we provide institutional investors with tailored access to private markets via three investment strategies:
commitments to primary funds, secondary transactions, and direct equity coinvestments.

Blocs de la page

Buyout

 

We invest our own capital in the Small-mid and Mid-large buyout segments to support the transformation efforts of highpotential companies and accelerate their international expansion. We work alongside management teams, helping our investees 
to strengthen and scale up in three main ways: through international expansion, digital transformation and acquisitions.

We invest on behalf of Eurazeo and our partner investors, in companies that have solid fundamentals, established positions in promising markets, real growth potential and ambitious management teams.

We favor the life sciences, tech, financial services and consumer goods sectors, in which we have proven, well-known expertise. Our team identifies the best investment opportunities in those sectors and provides unrivaled strategic and operational support to our portfolio companies.

We work alongside managers, helping our investees to strengthen and grow in three main ways: through international expansion, digital transformation and acquisitions.

We bring them the financial, strategic and human resources they need. This includes an effective on-the-ground presence in four continents – giving them easier access to new markets, particularly in China – along with a dedicated team of digital experts skilled in optimizing operational performance. Our buyout teams are also backed up by Eurazeo’s corporate departments and an international network of more than 120 high-level experts.

  • 50

    expertsin Europe

  • €10.3

    billionof Assets Under Management (AuM) as of 31/12/2023

  • 29

    portfoliocompanies

Mid-large buyout

Our specialists based in Europe and the United States, investing in marketleading companies with valuations of over €300 million. We are the partner of choice for medium-sized companies with major development ambitions. To help them achieve their goals, Eurazeo brings its wide range of expertise, global network and financial resources.

We are the partner of choice for managers who want to grow their businesses. We provide them with leading-edge expertise, a team of committed experts, a global network and financial resources to match their ambitions.

Small-mid buyout

We invest in French companies with valuations of €50 million to €250 million. We have 18 professionals specializing in this market segment, working with companies to bolster their business models and become global enterprises.

olivier-millet.jpg
We help French SMEs expand internationally, to turn them into mid-cap companies. We maintain daily contact with them, helping them to set up the necessary structures, introduce new processes and raise non-financial challenges.
Olivier Millet, Member of Eurazeo Executive Board, Small-mid buyout, Chairman of the Executive Board of EMC

China: a fund to accelerate startups’ development

The Eurazeo China Acceleration Fund’s mission is to invest alongside Eurazeo in French and European companies operating in sectors with strong growth potential in the Chinese market, and to support them with their strategies. Eurazeo is responsible for managing the fund, including selecting and managing investments. Since it was created the fund – set up in partnership with sovereign fund China Investment Corporation and BNP Paribas – has invested in DORC, Questel and Utac Ceram.

Latest news

Vignette
I Tracing

10/06/2024 - PRESS RELEASES

Eurazeo and the management of I-Tracing enter into exclusive discussions with a view to welcoming Oakley as a reference shareholder

min

Vignette
Eres Vignette

22/04/2024 - PRESS RELEASES

Eurazeo to invest in Eres Group, the leading French independent player in profit-sharing solutions and retirement schemes

1 min

Vignette
Dorce-2024

03/04/2024 - PRESS RELEASES

Eurazeo completes the sale of DORC to Carl Zeiss Meditec AG

1 min

Vignette
Humens

19/12/2023 - PRESS RELEASES

Eurazeo announces the sale of its stake in Humens

1 min

Vignette
Visuel DORC

17/12/2023 - PRESS RELEASES

Eurazeo enters into exclusive discussions with Carl Zeiss Meditec AG to sell its stake in DORC

1 min

Vignette
efeso

27/11/2023 - PRESS RELEASES

Eurazeo and EFESO Partners have signed an agreement

1 min

Vignette
BMS

28/09/2023 - PRESS RELEASES

Eurazeo completes its investment in BMS Group

1 min

Vignette
Eurazeoviews2-Girard-morin

19/09/2023 - TRIBUNE

Making the most of ESG reporting

4 min

Vignette
Eurazeoviews2-Mombert-Sesboue-Meignen

19/09/2023 - TRIBUNE

A promising future for Tech M&A

5 min

Vignette
Eurazeoviews2-Ordi-Cassam-Lariviere-Zins

19/09/2023 - TRIBUNE

The revolution in the healthcare sector

5 min

Vignette
Image Eurazeo Conviction Paper Healthcare

09/01/2023 - PUBLICATIONS

Conviction paper : Healthcare

1 min

Vignette
Image BMS Group

23/12/2022 - PRESS RELEASES

Eurazeo to invest in BMS group, a high growth independent (re)insurance broker, alongside BCI, PCP and management

1 min

Vignette
Vignette NEOXAM

21/11/2022 - PRESS RELEASES

Eurazeo signs an agreement to invest in NeoXam

1 min

Vignette
Conviction paper assurance home

06/09/2022 - PUBLICATIONS

Conviction paper : Insurance

1 min

Vignette
Vignette Fond Eurazeo PME

19/07/2022 - PRESS RELEASES

Eurazeo raises over €1 billion for Eurazeo PME IV fund

1 min

Vignette
Vivaprotech vignette

12/07/2022 - PRESS RELEASES

Eurazeo enters into exclusive discussions with Apax Partners for the sale of its majority stake in Vitaprotech

1 min

Vignette
Vignette Orolia

07/07/2022 - PRESS RELEASES

Eurazeo completes the sale of its stake in Orolia Group

1 min

Vignette
Vignette Trader Interactive

29/06/2022 - PRESS RELEASES

Eurazeo to sell the remaining 51% of its stake in Trader Interactive

1 min

Vignette
Vignette WiiSmile

15/06/2022 - PRESS RELEASES

Eurazeo signs an agreement to invest more than €70 million in WiiSmile

1 min

Vignette
Visuel Dilitrust

18/03/2022 - PRESS RELEASES

Exclusivity with a view to investing in DILITRUST

1 min

Vignette
Cranial Technologies

26/01/2022 - PRESS RELEASES

Eurazeo invests in cranial technologies, the market leader in treating infant plagiocephaly

1 min

Information - Individual investors

Eurazeo Investment Manager (EIM) and Eurazeo Mid Cap (EMC) are merging to form Eurazeo Global Investor (EGI)